Affordable, Targeted Genomic Testing for Precision Oncology in India
OncoTarget® is a disease-specific targeted NGS panel designed to identify key genomic alterations in major cancers, including Bladder, Breast, Colon, GI, Lung, Melanoma, Ovary, Prostate, Rectal, and Thyroid.
It offers a practical, affordable solution for guiding personalized therapy decisions in real-world clinical practice.
Accessible Genomic Insights for Every Patient
Not every case needs expensive, broad genomic panels.
OncoTarget® focuses on detecting guideline-recommended, clinically actionable mutations — making precision oncology more accessible, affordable, and easy to implement across India’s healthcare landscape.
Affordable targeted genomic testing customized to major cancer types
Deep sequencing of critical disease-specific genes
Easily understandable reports for quicker treatment planning
Option to customize up to 20 genes per cancer type
Optional add-on for PD-L1 expression testing (tissue only)
Analysis and active reporting powered by the iCare™ AI platform
How It Works
1) Disease-Specific Target Capture
Hybrid capture-based sequencing focused on clinically relevant genes, reducing unnecessary data and cost.
2 ) Customizable Panel Design
Ability to customize up to 20 high-priority genes for each cancer type based on clinical need.
3) AI-Driven Interpretation
Proprietary AI-based platform simplifies data interpretation, providing clear clinical recommendations aligned with NCCN, ASCO, and ESMO guidelines.
4) Actionable Reporting
Reports include tiered variant classification, pharmacogenomics insights (limited to DPYD), and appropriate therapy suggestions.
Applications
For Clinicians & Oncology Teams
Guide therapy selection based on actionable genomic mutations
Improve speed of decision-making for cancer patients
Support treatment monitoring and resistance identification
For Diagnostics Labs & Hospitals
- Offer cost-effective precision testing solutions
- Integrate easily into existing pathology and molecular workflows
Why OncoTarget®?
Affordable, focused testing designed for India’s clinical settings Customized panels built around the most critical genomic targets Faster, easier-to-interpret reports for guiding precision care Seamless sample collection process with flexible options for tissue or blood
Specimen Requirements
| Sample Type | Plasma cDNA (BD PAXgene tube) + optional peripheral blood (K2EDTA) OR 1 FFPE tissue block (20–30% tumor content, ≤ 3–4 months old) |
| Sample Collection | Peripheral blood via butterfly needle or 22G syringe |
| Sample Volume | 2 PAXgene tubes + 1 K2EDTA tube OR 1 FFPE block |
| cfDNA/DNA Input Amount | >1 ng |
| Sequencing Platform | Illumina (2 × 150 bp paired-end) |
| Mean Sequencing Depth | 2000x / 10000x |
| Sequencing Chemistry | Hybrid capture |
| Indications | Clinically diagnosed cancers associated with OncoTarget® panels |
| Analysis Platform | iCare™ AI-based analysis and reporting |
Key Actionable Genes Covered
Lung
EGFR, ALK, KRAS, ROS1, MET, RET, HER2, PIK3CA, BRAF
Breast
BRCA1, BRCA2, HER2, PIK3CA, ESR1, PALB2
Colorectal
KRAS, NRAS, BRAF, ERBB2, PIK3CA, TP53
Gastrointestinal
KIT, ALK, KRAS, NRAS, BRAF, ROS1, RET
Ovary
BRCA1, BRCA2, MTOR, MSI markers
Prostate
BRCA1, BRCA2, CHEK2, PALB2, RAD51D
Bladder
FGFR1, FGFR2, FGFR3, HER2, MSI markers
Melanoma
BRAF, NRAS, CDKN2A
Thyroid
BRAF, ALK, RET, NTRK1/2/3, MSI markers
